| Company Name | Fiscal Year | EPS (Actual) | EPS (Estimated) | Revenue (Actual) | Revenue (Estimated) | Exchange | |||
|---|---|---|---|---|---|---|---|---|---|
| Loading past events... | |||||||||
|
Tuesday - Sep 24, 2019 |
|||||||||
| Q1 FY20 | $0.86 | $0.70 | $10.66B | $8.68B |
NYSE |
||||
Jabil
JBL
|
Q4 FY19 | $0.88 | $0.86 | $6.57B | $6.50B |
NYSE |
|||
| Q3 FY19 | $3.30 | $2.86 | $6.20B | $5.38B |
NYSE |
||||
CarMax
KMX
|
Q2 FY20 | $1.40 | $1.33 | $5.20B | $4.94B |
NYSE |
|||
| Q4 FY19 | $22.59 | $21.80 | $3.99B | $3.85B |
NYSE |
||||
| - | $0.58 | $0.54 | $1.81B | $1.68B |
NASDAQ |
||||
|
Neogen
NEOG
|
Q1 FY20 | $0.14 | $0.15 | $101.42M | $108.67M |
NASDAQ |
|||
|
Comtech Telecommunications
CMTL
|
Q4 FY19 | $0.25 | $0.10 | $176.37M | $70.55M |
NASDAQ |
|||
|
Natural Alternatives International
NAII
|
- | -$0.03 | - | $30.26M | - |
NASDAQ |
|||
|
Perspective Therapeutics
CATX
|
Q4 FY19 | -$0.02 | -$0.02 | $1.92M | $1.92M |
AMEX |
|||
|
Relmada Therapeutics
RLMD
|
- | -$0.44 | - | - | - |
NASDAQ |
|||
| Show 1 more companies | |||||||||
